Literature DB >> 1119901

Human growth hormone response to levodopa. Relation to menopause, depression, and plasma dopa concentration.

E J Sachar, N Altman, P H Gruen, A Glassman, F S Halpern, J Sassin.   

Abstract

After ingestion of 500 mg of levodopa, postmenopausal women had significantly diminished human growth hormone (HGH) responses (mean, 4.6 ng/ml), as compared with those of age-matched men (mean, 9.1 ng/ml; P smaller than .05). The differences between the groups were not related to plasma dopa concentrations. The HGH responses to levodopa of age-matched unipolar and bipolar depressed men, and of unipolar depressed postmenopausal women, did not differ significantly from their respective normal control groups. Depressive illness of these types does not appear to affect the HGH response to levodopa, once the effect of the menopause is taken into account.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1119901     DOI: 10.1001/archpsyc.1975.01760220114011

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  6 in total

Review 1.  Clinical pharmacokinetics of levodopa in parkinson's disease.

Authors:  J R Bianchine; G M Shaw
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

2.  Effects of lithium carbonate on methylphenidate-induced mood, behavior, and cognitive processes.

Authors:  L Y Huey; D S Janowsky; L L Judd; A Abrams; D Parker; P Clopton
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

3.  Growth hormone secretion in empty sella syndrome.

Authors:  K Brismar
Journal:  J Endocrinol Invest       Date:  1982 Nov-Dec       Impact factor: 4.256

4.  [Biochemical research in depression (author's transl)].

Authors:  O Benkert
Journal:  Klin Wochenschr       Date:  1979-07-03

5.  Changes in noradrenergic neuroendocrine responses following repeated seizures and the mechanism of action of ECT.

Authors:  J R McWilliam; B S Meldrum; S A Checkley
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

6.  Growth hormone release after desipramine in depressive illness.

Authors:  P Meesters; M Kerkhofs; G Charles; C Decoster; M Vanderelst; J Mendlewicz
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1985
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.